Pharmabiz7h
Angelini Pharma, Cureverse enter exclusive global option agreement to develop & commercialize innovative brain health asset, CV-01
Angelini Pharma, Cureverse enter exclusive global option agreement to develop & commercialize innovative brain health asset, CV-01: Rome, Italy Tuesday, October 22, 2024, 17:00 Hr ...
Pharmabiz8h
Foresee Pharma announces preliminary results from phase 1 trial, highlighting promising safety, tolerability and PK profile of linvemastat
Foresee Pharma announces preliminary results from phase 1 trial, highlighting promising safety, tolerability and PK profile of linvemastat: Taipei, Taiwan Tuesday, October 22, 202 ...
Pharmabiz10h
Sarvam gears up to make healthcare and financial assistance easier and more accessible for workers with a community for D2C engagement
Sarvam gears up to make healthcare and financial assistance easier and more accessible for workers with a community for D2C engagement: Our Bureau, Mumbai Tuesday, October 22, 202 ...
Pharmabiz10h
Lupin appoints Claus Jepsen as president, global specialty
Global pharma major Lupin Limited (Lupin) announced the appointment of Claus Jepsen as president, global specialty. He brings ...
Pharmabiz11h
Relief Therapeutics to receive European patent covering RLF-TD011 for epidermolysis bullosa wound treatment
Relief Therapeutics to receive European patent covering RLF-TD011 for epidermolysis bullosa wound treatment: Geneva Tuesday, October 22, 2024, 13:00 Hrs [IST] Relief Therapeutics ...
Pharmabiz12h
Oculis Holding accelerates enrollment in both DIAMOND phase 3 trials of OCS-01 in diabetic macular edema
Oculis Holding accelerates enrollment in both DIAMOND phase 3 trials of OCS-01 in diabetic macular edema: Zug, Switzerland Tuesday, October 22, 2024, 12:00 Hrs [IST] Oculis Holdin ...
Pharmabiz16h
Gujarat has two new and one upgraded drug testing lab in Surat, Rajkot and Vadodara: Dr Koshia
Gujarat has two new and one upgraded drug testing lab in Surat, Rajkot and Vadodara: Dr Koshia: Shardul Nautiyal, Mumbai Tuesday, October 22, 2024, 08:00 Hrs [IST] Gujarat’s bur ...
Pharmabiz16h
Exporters seek tax relief as govt delays response on Section 43B (h)
The pharmaceutical exporters in the country are keenly awaiting a government response to their call for an exemption from the stringent payment conditions under Section 43B (h) of the Income Tax (IT) ...
Pharmabiz16h
Digital transformation of TN DCA increased efficiency of licensing process in TN: M Sridhar
Digital transformation of TN DCA increased efficiency of licensing process in TN: M Sridhar: Peethaambaran Kunnathoor, Chennai Tuesday, October 22, 2024, 08:00 Hrs [IST] The digit ...
Pharmabiz13h
Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare
Sanofi and CD&R announce a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion. Sanofi and CD&R have entered exclusive negotiations for the ...
Pharmabiz16h
Indian healthcare industry sees advanced on-site 3D printing lab to simplify preoperative planning
The Indian healthcare industry is of the view that the advanced on-site 3D printing lab will simplify preoperative planning, surgical guidance, individualize implants, and customize prostheses across ...
Pharmabiz16h
DoP rejects review application of Pfizer Ltd against ceiling price fixation of Wysolone DT
DoP rejects review application of Pfizer Ltd against ceiling price fixation of Wysolone DT: Gireesh Babu, New Delhi Tuesday, October 22, 2024, 08:00 Hrs [IST] The Department of Ph ...